KSB Targets Double-Digit Growth After Supply-Chain Hit

KSB Limited — Q2 CY2026 Institutional Investors Meet (19 Aug 2026)

1. Overall Tone of Management

Optimistic
Management repeatedly emphasizes “robust orders on hand”, “momentum gaining now going forward” (nuclear), and expects to “cover up what we lost in the first half” with “double-digit growth” as the goal. Even when discussing issues (exports, supply chain, nuclear testbed delays), responses are framed as temporary and progressing (e.g., supply chain “85% to 90% stability”).

2. Key Themes from Management Commentary

• Strong H1 topline growth + order momentum
• Revenue/EBITDA/PAT growth framed as sustained (CAGR references) and order intake growing (14% CAGR).
• Orders on hand: INR 27,445 million (June 2026); nuclear excluded OI INR 15,307 million.
• Energy remains the primary growth engine
• Conventional thermal pump packages (boiler feed pump, condensate transfer pumps, refinery/hydrocarbon pumps) plus localized boiler circulation pump success.
• Water/Wastewater and Building Services as expanding infrastructure bets
• Municipal water, desalination, rural water; and building services opportunities (metro/airports/commercial real estate; firefighting product range).
• Exports: geopolitical disruption acknowledged, recovery expected
• “Geopolitical pause/hassles” impacted H1 exports; management expects normalization in H2.
• Nuclear: long-cycle opportunity, but execution timing is the key variable
• Facility readiness and localization capability emphasized (ISO-19443, capacity expansion).
• Execution delays tied to NPCIL test bed issues; confidence maintained due to limited testing results and expected resolution.
• Cost/margin pressure explained as supply-chain + mix + sales shortfall
• Valves margin drop to single digits attributed to commodity prices, product mix, exports down, and sales down; framed as temporary.
• Digital/ERP transformation (SAP S/4HANA)
• “Mandatory” upgrade; benefits described (efficiency, automation), with opex impact next year acknowledged.

3. Q&A Analysis

Theme A: Macro outlook & sector growth breakpoints

• Core questions
• Where can pump industry growth exceed “~1x GDP” over the next 2–4 years?
• Can thermal (e.g., 50 GW under construction) lift sector growth meaningfully?
• Management response
• Energy leads (nuclear + conventional + renewable) and infrastructure (water/wastewater, airports/metros/railways) supports growth.
• Thermal expected to provide “extra over normal growth” due to localization success and boiler circulation pump order momentum.
• Notable/strong vs evasive
• No hard numbers on sector growth uplift; relies on qualitative confidence and “momentum picks up” narrative.

Theme B: Nuclear execution, testing timelines, revenue recognition, competition

• Core questions
• Status of GHAVP testbed issues and when testing resumes/completes.
• When will Kaiga testing start and when will KSB recognize revenue?
• Whether additional suppliers (Kirloskar/Flowserve) will compete for primary coolant pumps.
• Management response
• GHAVP: testing started April/May; issues in NPCIL test bed; expected solved by end of August, testing in September.
• Testing duration: first pump 500 hours (~2–3 months), dispatches after; “one pump every quarter” but can go up to six pumps/year.
• Kaiga: testing after GHAVP test; revenue recognition tied to dispatches after testing.
• Competition: management says “as of today, we are the approved supplier” and emphasizes learning curve/localization; also acknowledges NPCIL may seek alternative vendors in future.
• Evasive/partial
• Some uncertainty remains on tender timing (“should come in next few months” / “don’t know when it will come”).
• Competition question answered with confidence but limited specifics on probability/timing of vendor approvals.

Theme C: H1 subdued performance—exports, supply chain, margins

• Core questions
• Why performance was subdued in the quarter/H1; export share to Middle East.
• Whether supply chain issues are resolved and whether exports are back on track.
• Valves margin compression: why single-digit margins vs historical mid-teens.
• Management response
• Subdued H1: geopolitical war affecting exports + supply chain issues (castings/material not available).
• Supply chain: “85% to 90% stability” after revised price agreements; export activity started but “results have yet to come.”
• Valves margin: commodity prices + product mix + exports down + sales down; “temporary variations.”
• Notable/strong vs evasive
• Strong admission: “we could not get all the castings and the material… equally impactful” (supply chain, not just geopolitics).
• Export recovery framed as “momentum” but not yet evidenced by results.

Theme D: Data centre opportunity & competitive intensity

• Core questions
• Global presence in data centres; competitive intensity; whether KSB can win share.
• Management response
• Orders coming to KSB Germany from Europe OEMs; in India, focus on liquid cooling applications and OEM partnerships.
• Dedicated teams and product adaptation for OEM specs.
• Notable
• No quantified market share; relies on order book satisfaction and “good share” expectation.

Theme E: Solar business—KUSUM 2.0 delay, order book share, guidance

• Core questions
• Solar revenue in H1, YoY growth, KUSUM 2.0 timing impact.
• Solar pumps share in current order book; guidance for KUSUM 2.0.
• Management response
• Solar H1 revenue: INR 50–60 crores, below expectations due to KUSUM 2.0 delayed to last quarter/second half.
• Current solar order book share: 5%–7% vs target 10%–12%.
• Expects orders from recent tenders (e.g., Maharashtra) to help Q3; hopes for share gain when KUSUM 2.0 launches.
• Notable/partial
• Clear acknowledgment of underperformance vs plan; no hard solar revenue guidance beyond “should help” language.

Theme F: Order intake composition & what’s pulling it down

• Core questions
• Why order intake didn’t improve materially vs last quarter despite new emerging sectors.
• Which sectors are slowing (oil & gas/petrochemical, engineered pumps, etc.).
• Management response
• Standard business growing consistently; project business slowed due to oil & gas/petrochemical timing.
• Boiler circulation pump localization success expected to spur thermal momentum.
• Water/wastewater and mining are “seeds” requiring product acceptance cycles.
• Notable
• Management links order intake to both standard and project cycles; admits some project timing softness.

Theme G: Working capital, price pass-through, Capex

• Core questions
• Receivable days trend; improvement in H2?
• Gas availability/cost pass-through and margin impact.
• Capex adequacy and duration.
• Management response
• Receivables: improvement expected in H2; solar documentation/state government fund availability drives timing.
• Gas/cost: foundries impacted; now 85–90% stability; margin lag due to time for customer price reflection (3–6 months).
• Capex: ongoing sustenance + growth; annual investment “INR 80–120 crores” and also investment in offices/employee engagement; no explicit capex end-date.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Growth goal: “Our goal is to have a double-digit growth” (full-year aim).
• Margin target: EBITDA “13–14%” (stated as desired level).
• Solar order book share target: “10% to 12%” (current 5%–7%).
• Export order book target: current export order book described as “~15% of orders/sales” and “want to target 20%.”
• Capex run-rate: “INR 80 crores, INR 100 crores, INR 120 crores annually” (investment range).
• Nuclear testing cadence: first pump 500 hours (~2–3 months); “one pump every quarter” up to “six pumps per year” (operational expectation).

Implicit signals (qualitative)

• H2 recovery expectation: management expects to “cover up what we lost in the first half.”
• Nuclear execution confidence: comfortable due to limited testing performance and expected resolution of test bed issues.
• Valves margin normalization: “temporary variations” and expectation to return to “double-digit margin.”
• ERP/S/4HANA: operational efficiency benefits, but opex impact next year is acknowledged.

5. Standout Statements (direct / high-signal)

• Supply chain as a primary driver of H1 weakness:
• “we could not get all the castings and the material what we needed to deliver…”
• Supply chain stabilization level:
• “almost 85% to 90% stability…”
• Nuclear testbed issue timeline:
• “by end of August… testing should start in September.”
• Nuclear execution comfort despite delays:
• “during the limited testing… we see the pump performing as per the expectations…”
• Full-year growth ambition:
• “Our goal is to have a double-digit growth.”
• Valves margin explanation (multi-factor, framed temporary):
• “partly due to the commodity prices… product mix… exports have been down… sales being down…”
• Solar underperformance vs plan:
• “much below than our expectations or planning… due to the KUSUM scheme… delayed.”
• ERP cost risk acknowledged:
• “there will be an impact next year on S/4HANA… in the Opex.”

6. Red Flags / Positive Signals

Red flags
– Execution risk remains in nuclear due to NPCIL test bed dependencies (timing uncertainty persists).
– Exports not yet “back on track”: activity started, but “results have yet to come.”
– Margin volatility: valves margin dropped to single digits; management attributes to temporary factors but provides no quantified recovery timeline.
– Price pass-through lag: margin impact persists even after supply stabilization due to fixed-price project dynamics and delayed reflection (3–6 months).

Positive signals
– Clear operational stabilization: supply chain “85–90% stability.”
– Nuclear readiness + localization credibility: ISO-19443, expanded capacity, and “comfortable” performance in limited testing.
– Order book strength: June 2026 orders on hand INR 27,445 million; continuous order intake growth.
– Aftermarket/SupremeServ momentum: described as profitable and growing; target growth to 25–30% (with caveats).

7. Historical Comparison & Consistency Analysis (vs prior 3 calls)

a. Change in Tone Over Time

• More Cautious vs earlier optimism (Nov 2025 / Mar 2026 were more “flowing” and less execution-friction focused).
• What changed
• Current call emphasizes H1 weakness and supply chain/castings/material availability plus NPCIL test bed issues.
• Still optimistic on H2 recovery, but language includes more timing qualifiers (“should”, “given to understand”, “momentum gaining now”).
• Guidance remains “double-digit growth,” but nuclear execution uncertainty is more explicit than in earlier calls.

b. Tracking Past Commitments vs Outcomes

• Nuclear testing start / delivery timing
• Prior (Nov 2025): expectation that testing would start around “next month/first half of Jan” for some pumps; also “deliver few pumps this year” language.
• Current (Aug 2026): GHAVP testing delayed due to NPCIL test bed issues; testing expected September; revenue recognition tied to dispatches after testing.
• Assessment: ⏳ Delayed (execution timing has slipped again; management continues to reframe with “issues at test bed”).
• Solar KUSUM 2.0 timing
• Prior (Mar 2026): KUSUM 2.0 expected to drive CY27; CY26 “covered” with expectation of scheme coming.
• Current (Aug 2026): KUSUM 2.0 delayed to last quarter/second half, causing solar H1 revenue below expectations.
• Assessment: ⏳ Delayed (scheme timing continues to push solar share down vs target).
• Valves margin normalization
• Prior: valves margins described as healthy/double-digit historically.
• Current: valves margin dropped to single digits; management says “temporary variations.”
• Assessment: ⏳ Not yet delivered (no evidence of recovery yet).

c. Narrative Shifts

• From “order book strength converts to sales” → “conversion depends on external test bed readiness”
• Earlier calls leaned on backlog conversion timelines; now more emphasis on NPCIL test bed and supply chain castings.
• Exports narrative
• Earlier: export growth momentum and acceptance building.
• Current: geopolitical disruption + clear statement that export results are not yet back despite inquiries.
• Solar narrative
• Earlier: learning curve improving; now: KUSUM 2.0 delay is again the dominant driver of underperformance.

d. Consistency & Credibility Signals

• Medium credibility
• Positives: management provides specific operational reasons (castings/material, test bed issues, price agreement stabilization).
• Negatives: repeated timing deferrals (nuclear testing/revenue recognition; KUSUM 2.0 impact) without firm completion dates.
• Pattern: “temporary” issues recur across segments, suggesting execution dependencies are harder than initially implied.

e. Evolution of Key Themes

• Demand / orders: improving/stable (order intake and orders on hand remain strong).
• Margins: deteriorated in valves (single digits) and pressured by project sales shortfall and fixed-price dynamics.
• Nuclear: theme remains bullish long-term, but near-term execution has become more fragile due to test bed dependencies.
• Digital/ERP: new operational theme (S/4HANA cost/opex impact next year).

f. Additional Insights (cross-period intelligence)

• Margin pressure is increasingly linked to “sales shortfall vs plan”, not just commodity costs:
• Current call: “did not achieve our planned sales… major reason of having an impact on the EBIT.”
• Management is using “stability” language for supply chain but still sees inventory/clearance delays:
• Exports clearances and inventory still being worked through (“not to that extent… diluting and finding ways to deliver”).
• Aftermarket is positioned as a stabilizer against project margin volatility, but the call does not provide new hard KPIs to prove acceleration vs prior expectations.